UNSPSC 51432706: Ramiprilat

This classification denotes an ace inhibitor with the molecular formula C21H28N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6N5U4QFC3G, chemically known as (2s,3as,6as)-1-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid but generally known as ramiprilat, which bears US NIH Compound Identifier 5464096. European Medicines Agency schedules Ramiprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10249MIG.

UNSPSC 51432706 Ramiprilat is a Commodity code encompassing pharmaceutical active pharmaceutical ingredients and finished medications procured by state and local health systems, emergency services, and multi-state cooperative purchasing consortia. State and local governments buy specific medications under this code through multiple channels: direct emergency-response procurement (such as Advanced Life Support medications for fire departments), state Medicaid and health agency pharmacy programs, and cooperative purchasing arrangements spanning multiple states and local jurisdictions. Issuing bodies include municipal fire and emergency services departments, state health and human services commissions, and multi-state cooperative purchasing alliances like MMCAP that aggregate demand across state agencies and local government facilities. The scope covers both generic pharmaceutical products supplied through established wholesaler networks and specialized medications required for acute care delivery, with vendors expected to manage supply chain relationships with authorized distributors, maintain current Good Manufacturing Practice certification, comply with Drug Supply Chain Security Act requirements, and provide Safety Data Sheets and accessibility documentation.

Recent activity spans Texas, Minnesota, Florida, and cooperating western states. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (Epinephrine, Adenosine, Diltiazem, and Labetalol) for Tampa Fire Rescue, with a response deadline of April 8, 2026 and an estimated contract value of $40,000, featuring a 5 percent bid discount for Small Local Business Enterprise participation. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with responses due March 26, 2026 and contract effectiveness July 1, 2026; the RFP weighted price competitiveness at 75 percent of evaluation scoring. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program intended to inform future formal procurement strategy outside traditional PBM and GPO channels.